Clinical Trials Logo

Generalized Anxiety Disorder clinical trials

View clinical trials related to Generalized Anxiety Disorder.

Filter by:

NCT ID: NCT05883774 Not yet recruiting - Clinical trials for Generalized Anxiety Disorder

Effects of rTMS on the Anxiety State of Older Patients With GAD

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of low-frequency repetitive transcranial magnetic stimulation on anxiety state in older patients with generalized anxiety disorder.

NCT ID: NCT05849493 Recruiting - Clinical trials for Generalized Anxiety Disorder

Effects and Mechanisms of Change of Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder

ORIGAMI
Start date: May 19, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare two psychological treatments for Generalized Anxiety Disorder. The main questions it aims to answer are: How well do these treatments work compared to earlier studies? Is one of the treatments more effective than the other? Are the treatments working the way that we think they do? Specifically, do changes in the variables that these treatments aim to target predict changes in anxiety symptoms? Participants will be randomized to two different internet-based cognitive behavioral therapy (ICBT) programs: Intolerance of uncertainty-based ICBT and metacognition-based ICBT. Both programs consist of 8 treatment modules and run for 10 weeks. A psychologist will respond to the participants assignments and exercises and will respond to messages.

NCT ID: NCT05820568 Completed - Clinical trials for Generalized Anxiety Disorder

Internet Delivered Cognitive Behavior Therapy Based on Intolerance of Uncertainty

ORIGAMI
Start date: November 2, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical is to pilot test an internet delivered cognitive behavior therapy (ICBT) based on intolerance of uncertainty (one of several existing specific cognitive models for how worry works) in treating generalised anxiety disorder (GAD). The main aims is to: - Test the preliminary effect of the intervention in lowering symptoms of GAD as measured by the self report scale GAD-7 - Test procedures for recruitment, assessment, treatment and follow up - Test the acceptability of the intervention as measured by the Client Satisfaction questionnaire-8, dropout and adverse events Participants will apply for treatment in an online system, be assessed via video by a licensed clinical psychologist and then receive a 10 week long ICBT intervention based on the intolerance of uncertainty model. This is a pilot study for an upcoming randomized controlled trial.

NCT ID: NCT05800925 Recruiting - Clinical trials for Major Depressive Disorder

Triage Survey for Psychiatry Research Eligibility

TRIAGE-Psych
Start date: December 21, 2021
Phase:
Study type: Observational

TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.

NCT ID: NCT05785312 Not yet recruiting - Clinical trials for Major Depressive Disorder

Development of Online EMDR Therapy System and Its Comparative Testing With Face-to-Face EMDR Therapy for Treatment of Anxiety and Depressive Disorders in Pakistan

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

This study aims at developing an online system for the remote delivery of EMDR therapy in Pakistan. Moreover, this study will compare the efficacy of online EMDR therapy with face-to-face EMDR therapy.

NCT ID: NCT05772104 Not yet recruiting - Clinical trials for Generalized Anxiety Disorder

Randomized Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

Start date: March 10, 2023
Phase: Phase 3
Study type: Interventional

This trial was a multi-center, randomized, double-blind, two-stage clinical trial in patients with generalized anxiety disorder (TCM differentiated as liver Qi stagnation and spleen deficiency syndrome), consisting of a exploratory study(stage 1) and a confirmatory study(stage 2). In stage 1, 120 subjects were enrolled and randomly assigned to high-dose group, low-dose group and placebo group at a ratio of 1:1:1. In stage 2, 440 subjects (final sample size was re-estimated based on the results of stage 1) were randomly assigned to the experimental and placebo groups at a ratio of 1:1.

NCT ID: NCT05749055 Recruiting - Clinical trials for Generalized Anxiety Disorder

ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder

ENCALM
Start date: July 3, 2023
Phase: Phase 2
Study type: Interventional

The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)

NCT ID: NCT05748652 Completed - Clinical trials for Generalized Anxiety Disorder

Generalized Anxiety Therapy Effectiveness

GATE
Start date: March 6, 2023
Phase: N/A
Study type: Interventional

This study will examine the effectiveness of digital CBT versus psychoeducation in improving anxiety for those with Generalized Anxiety Disorder.

NCT ID: NCT05729373 Recruiting - Clinical trials for Generalized Anxiety Disorder

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Start date: March 8, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

A clinical study that will meaure how well SEP-363856 works and how safe it is in adults with Generalized Anixety Disorder. This study will be accepting both male and female subjects between the ages of 18 years and 65 years old. The study will be held in Approximately 50 global study centers and approximately 15 additional centers for a separate Japan population. Participation in the study can be up to approximately 12 weeks.

NCT ID: NCT05717439 Recruiting - Clinical trials for Major Depressive Disorder

Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults With PTSD

Start date: March 1, 2023
Phase:
Study type: Observational

The aim of this study is to obtain data on the feasibility of the Senseye Diagnostic Tool (DT) to assess the presence and severity of post-traumatic stress disorder (PTSD) symptoms. The study will also collect data on Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD) to aid in assessing the presence and severity of these disorders both for the purpose of discerning them from PTSD and determining the feasibility of diagnosing them independently.